Home/Filings/4/0001104659-24-112755
4//SEC Filing

Brunke Karen J 4

Accession 0001104659-24-112755

CIK 0001175680other

Filed

Oct 29, 8:00 PM ET

Accepted

Oct 30, 9:45 PM ET

Size

12.7 KB

Accession

0001104659-24-112755

Insider Transaction Report

Form 4
Period: 2024-10-28
Transactions
  • Award

    Non-qualified stock option (right to buy)

    2024-10-28+800,000800,000 total
    Exercise: $0.13Exp: 2034-10-28Common Stock (800,000 underlying)
Footnotes (2)
  • [F1]This grant was approved by the Company's Compensation Committee on October 28, 2024 and represents the annual grant awarded to the individual for fiscal year 2025. This award is made consistent with, and utilizes shares from, the Issuer's 2012 Equity Incentive Plan, as amended.
  • [F2]266,664 shares vested on the grant date, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from October 2024 through May 2025.

Issuer

CytoDyn Inc.

CIK 0001175680

Entity typeother

Related Parties

1
  • filerCIK 0001922660

Filing Metadata

Form type
4
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 9:45 PM ET
Size
12.7 KB